Table 1 Experimental design of five reduction in liver infection experiments showing group sizes
Experiment ID | Administrations (in vaccine groups) | Control groups (# mice/group) | Vaccine groups (# mice/group) | ||||||
|---|---|---|---|---|---|---|---|---|---|
AB317 | Naïve (No vaccine) | Background (d-luciferin) | RTS,S dose levels | ||||||
0.05 μg | 0.2 μg | 1 μg | 5 μg | 10 μg | |||||
2x Trial 1 | 2 | 5 | 5 | 2 | 5 | 5 | 5 | 5 | 5 |
2x Trial 2 | 2 | 5 | 5 | 2 | 5 | 5 | 5 | 5 | 5 |
2x Trial 3 | 2 | 5 | 5 | 2 | 5 | 5 | 5 | 5 | 5 |
3x Trial 1 | 3 | 5 | 5 | 2 | 5 | 5 | 5 | 5 | 5 |
3x Trial 2 | 3 | 5 | 5 | 2 | 5 | 5 | 5 | 5 | 5 |
